These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 15747987)

  • 21. Pathophysiology and treatment of patients with type 2 diabetes exhibiting failure to oral drugs.
    Efendic S; Alvarsson M; Brismar K; Wagner H
    Acta Physiol (Oxf); 2008 Jan; 192(1):117-25. PubMed ID: 18171434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential role of oral DPP-4 inhibitors in the ADA/EASD consensus statement algorithm for achieving and maintaining tight glycaemic control in type 2 diabetes: recommendations for oral antidiabetic agents.
    Barnett A
    Int J Clin Pract Suppl; 2007 Aug; (154):12-8. PubMed ID: 17593273
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of type 2 diabetes: oral agents, insulin, and injectables.
    Fonseca VA; Kulkarni KD
    J Am Diet Assoc; 2008 Apr; 108(4 Suppl 1):S29-33. PubMed ID: 18358251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. When oral agents fail: optimizing insulin therapy in the older adult.
    Meece J
    Consult Pharm; 2009 Jun; 24 Suppl B():11-7. PubMed ID: 19555131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Oral treatment of type 2 diabetes mellitus].
    Olsovský J
    Vnitr Lek; 2007; 53(7-8):853-4, 856-8. PubMed ID: 17915430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antidiabetic agents and renal insufficiency].
    Robles NR; Blanco J
    Nefrologia; 2002; 22(4):325-8. PubMed ID: 12369123
    [No Abstract]   [Full Text] [Related]  

  • 27. Comparison of glycaemic control in patients with Type 2 diabetes on basal insulin and fixed combination oral antidiabetic treatment: results of a pilot study.
    De Mattia G; Laurenti O; Moretti A
    Acta Diabetol; 2009 Mar; 46(1):67-73. PubMed ID: 19030772
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The DIACOM study (effect of DosIng frequency of oral Antidiabetic agents on the COMpliance and biochemical control of type 2 diabetes).
    Kardas P
    Diabetes Obes Metab; 2005 Nov; 7(6):722-8. PubMed ID: 16219016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of the effects of hypoglycemic agents on serum electrolytes in the diabetic patients.
    Javaid A; Hasan R; Zaib A; Mansoor S
    Pak J Pharm Sci; 2007 Jan; 20(1):67-71. PubMed ID: 17337432
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Achieving glycemic goals in type 2 diabetes.
    Bloomgarden ZT
    Diabetes Care; 2007 Jan; 30(1):174-80. PubMed ID: 17192357
    [No Abstract]   [Full Text] [Related]  

  • 31. [Practice of antidiabetic therapy in Hungary].
    Hankó BZ; Reszegi CA; Kumli P; Vincze Z
    Acta Pharm Hung; 2005; 75(2):77-86. PubMed ID: 16318232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biphasic insulin aspart 30 treatment improves glycaemic control in patients with type 2 diabetes in a clinical practice setting: Chinese PRESENT study.
    Gao Y; Guo XH; Vaz JA;
    Diabetes Obes Metab; 2009 Jan; 11(1):33-40. PubMed ID: 18494806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Practical review of oral antihyperglycemic agents for type 2 diabetes mellitus.
    Koski RR
    Diabetes Educ; 2006; 32(6):869-76. PubMed ID: 17102154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Starting insulin therapy in type 2 diabetes: lesson 2.
    McCall AL
    Curr Diab Rep; 2005 Oct; 5(5):326-8. PubMed ID: 16188165
    [No Abstract]   [Full Text] [Related]  

  • 35. From educated guess to accepted practice: the use of oral antidiabetic agents in pregnancy.
    Langer O
    Clin Obstet Gynecol; 2007 Dec; 50(4):959-71. PubMed ID: 17982339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral medicines for type 2 diabetes.
    Geil P; Hieronymus L
    Diabetes Self Manag; 2005; 22(4):6, 8-10, 12. PubMed ID: 16121426
    [No Abstract]   [Full Text] [Related]  

  • 37. [New oral antidiabetic agents and current strategies of peroral antidiabetic therapy (PAD)].
    Rybka J; Kvapil M
    Vnitr Lek; 2002 Jun; 48(6):517-22. PubMed ID: 12132353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacoepidemiology of diabetes: assessment of good use of oral antidiabetic drugs].
    Vauzelle-Kervroëdan F; Javoy F; Forhan A; Fender P; Eschwège E
    Diabetes Metab; 2000 Sep; 26 Suppl 6():63-8. PubMed ID: 11011241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy with new targets in Type 2 diabetes: a review of available agents with a focus on pre-exercise adjustment.
    McDonnell ME
    J Cardiopulm Rehabil Prev; 2007; 27(4):193-201. PubMed ID: 17667012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. How to select and combine oral agents for patients with type 2 diabetes mellitus.
    Chipkin SR
    Am J Med; 2005 May; 118 Suppl 5A():4S-13S. PubMed ID: 15850548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.